The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Too much support. Everyone calling him Stuart. I've never met him. I don't need to.
The difference between good leaders and the rest is vision... not being influenced by boards, bulletin or otherwise. Our mate Stu is coming up short and we're paying.
Please excuse any misunderstanding on my part.
For clarity, I'm assuming that Zak Mir's analysis is based on charts, market patterns and herd behaviour ( certainly not critical as too often charting has helped).
Regardless... presumably he is not taking into account any good news, but predicting that the current recent rise anticipates news.
I'm unsure if he's considering the current and future potential.
Rambling a bit because I'm trying to distinguish between discrete charting and news driven rises.
Perhaps they are more closely related than I thought.
However...the sun is out here in West Cornwall.... it's a welcome change to the northerly winds we've tolerated for so long.
I'll find a link between the SP and weather later.
Belgrano, good morning.
My sentiments exactly.
My ' fear' is that encouraging rises before positive news may be bought and sold.
We could benefit from more regular news albeit avoiding price sensitive information. Difficult perhaps but in the absence of news the sp will flounder at best.
Looking at the possibility of a delay in sales figures increasing, it's realistic to imagine yesterday's fall and today's rise becoming a pattern.
There are times when, for good reason, we hold too long. Ever the optimist we struggle to face the possibility we made a poor choice. The options are to sell and never look again at the SP ( we don't want to see success after we sell), or to hold and hope.
Unfortunately, others, less attached to a company/idea see only opportunity.
We all know this.
I'm not saying anything new.
It's just a feeling I have with sbtx.
I'll hold because we are 15% higher than January despite the fall. We recovered without any sales.
( I bought at 60p).
We have sales, therefore income.
Sales will increase because there's no alternative with a valuable remedy like this.
Therefore, it's unwise to sell.
May even buy more... but I missed the low.